{{Rsnum
|rsid=17134592
|Gene=AKR1C4
|Chromosome=10
|position=5260682
|Orientation=plus
|GMAF=0.1038
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 73.8 | 18.5 | 7.7
| HCB | 68.9 | 31.1 | 0.0
| JPT | 82.2 | 17.8 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 68.9 | 31.1 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21544809
|Title=Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
|OA=1
}}

{{PMID Auto
|PMID=20566993
|Title=Chlordecone exposure and risk of prostate cancer.
}}

{{PMID Auto
|PMID=21947678
|Title=Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
}}

{{GET Evidence
|gene=AKR1C4
|aa_change=Leu311Val
|aa_change_short=L311V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17134592
|overall_frequency_n=1223
|overall_frequency_d=10758
|overall_frequency=0.113683
|n_genomes=7
|n_genomes_annotated=0
|n_haplomes=8
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=1
|n_web_uneval=10
}}

{{on chip | HumanOmni1Quad}}